Podcasts360
Podcasts360
Consultant360
George Karpouzas, MD, on How bDMARDS Prevent CV Events in Patients With RA
10 minutes Posted Apr 10, 2020 at 4:34 pm.
0:00
10:09
Download MP3
Show notes
In this podcast, George Karpouzas, MD, talks about his study that evaluated whether biologic disease-modifying antirheumatic drugs reduce long-term risk of cardiovascular events in patients with rheumatoid arthritis, as well as their mechanism of action. More at: www.consultant360.com/rheumatology.